Baihua Pharmaceuticals: Jinhua Juxin plans to acquire 20.68% of the company's shares; trading resumes on April 8.

2026-04-10 14:13:38

Baohua Pharmaceutical announcement: The company’s controlling shareholder and actual controllers, Mi Zaizhi, Mi Enhua, Yang Xiaoling, and Jinhua Juxin, have signed a “Share Transfer Agreement.” They intend to transfer, by agreement, a total of 79.5251 million shares of the company’s unrestricted tradable shares they hold (accounting for 20.68% of the company’s total shares) to Jinhua Juxin. The total consideration for the transfer is 890 million yuan, equivalent to 11.19 yuan per share. After this transaction is completed, the company’s controlling shareholder will change to Jinhua Juxin, and the actual controller will change to the State-owned Assets Supervision and Administration Commission of the Jinhua Municipal People’s Government. The company’s stock will resume trading from the opening of April 8, 2026.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.